Indeed, not soon after the approval of Zoetis’ interleukin 31 (IL-31)-targeting antibody Cytopoint (lokivetmab) to treat atopic dermatitis in dogs, Galderma and Chugai Pharmaceutical agreed to ...
Preclinical studies conducted in South Korea have already demonstrated the safety and effectiveness of the oral therapy for treating atopic dermatitis in dogs. Results, published in Experimental ...